Passage Bio Ownership 2024 | Who Owns Passage Bio Now?
Institutional Ownership
68.84%
Insider Ownership
0.49%
Retail Ownership
30.68%
Institutional Holders
49.00
Passage Bio Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 18.43% | 0.25% | 10,124,576 | - | - | 13,668,178 | Mar 31, 2024 |
| VERSANT VENTURE MANAGEMENT, LLC | 9.03% | 6.49% | 4,959,769 | - | - | 6,695,688 | Mar 31, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | 8.82% | 1.70% | 4,845,871 | 4,466,712 | 1178.06% | 6,541,926 | Mar 31, 2024 |
| VESTAL POINT CAPITAL, LP | 8.19% | 0.50% | 4,500,000 | 4,500,000 | 100.00% | 6,075,000 | Mar 31, 2024 |
| NEW LEAF VENTURE PARTNERS, L.L.C. | 4.55% | 2.95% | 2,497,922 | - | - | 3,372,195 | Mar 31, 2024 |
| VANGUARD GROUP INC | 3.77% | 0.00% | 2,071,538 | 52,656 | 2.61% | 2,796,576 | Mar 31, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 2.73% | 0.21% | 1,500,000 | -900,000 | -37.50% | 2,025,000 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 2.19% | 0.00% | 1,205,524 | -17,827 | -1.46% | 1,627,000 | Mar 31, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.75% | 0.00% | 961,271 | 356,593 | 58.97% | 1,296,000 | Mar 31, 2024 |
| BLACKROCK INC. | 1.68% | - | 922,547 | -100,016 | -9.78% | 1,245,438 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.58% | 0.00% | 865,739 | 77,564 | 9.84% | 1,168,748 | Mar 31, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1.01% | 0.02% | 556,142 | 49,542 | 9.78% | 750,792 | Mar 31, 2024 |
| ACUITAS INVESTMENTS, LLC | 0.85% | 0.32% | 469,306 | 51,572 | 12.35% | 633,563 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.70% | - | 384,278 | 52,075 | 15.68% | 518,913 | Mar 31, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.48% | 0.04% | 264,266 | 264,266 | 100.00% | 356,759 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.40% | 0.00% | 221,552 | -90,161 | -28.92% | 299,095 | Mar 31, 2024 |
| FIDUCIARY TRUST CO | 0.39% | 0.00% | 215,000 | 100,000 | 86.96% | 290,250 | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | 0.38% | 0.00% | 209,600 | -900 | -0.43% | 282,960 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.37% | 0.00% | 201,153 | - | - | 271,557 | Mar 31, 2024 |
| RBF CAPITAL, LLC | 0.26% | 0.01% | 142,807 | - | - | 192,789 | Mar 31, 2024 |
Passage Bio's largest institutional shareholder is ORBIMED ADVISORS LLC, holding 18.43% of the company's total share outstanding, currently valued at $13.67M. The top 10 institutional shareholders own together 61.13% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VERSANT VENTURE MANAGEMENT, LLC | 9.03% | 6.49% | 4,959,769 | - | - | 6,695,688 | Mar 31, 2024 |
| NEW LEAF VENTURE PARTNERS, L.L.C. | 4.55% | 2.95% | 2,497,922 | - | - | 3,372,195 | Mar 31, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | 8.82% | 1.70% | 4,845,871 | 4,466,712 | 1178.06% | 6,541,926 | Mar 31, 2024 |
| VESTAL POINT CAPITAL, LP | 8.19% | 0.50% | 4,500,000 | 4,500,000 | 100.00% | 6,075,000 | Mar 31, 2024 |
| ACUITAS INVESTMENTS, LLC | 0.85% | 0.32% | 469,306 | 51,572 | 12.35% | 633,563 | Mar 31, 2024 |
| ORBIMED ADVISORS LLC | 18.43% | 0.25% | 10,124,576 | - | - | 13,668,178 | Mar 31, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 2.73% | 0.21% | 1,500,000 | -900,000 | -37.50% | 2,025,000 | Mar 31, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.48% | 0.04% | 264,266 | 264,266 | 100.00% | 356,759 | Mar 31, 2024 |
| DLK INVESTMENT MANAGEMENT, LLC | 0.12% | 0.04% | 64,000 | - | - | 86,400 | Mar 31, 2024 |
| PALE FIRE CAPITAL SE | 0.26% | 0.03% | 141,435 | -439,822 | -75.67% | 190,937 | Mar 31, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | 0.16% | 0.02% | 85,500 | - | - | 115,425 | Mar 31, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1.01% | 0.02% | 556,142 | 49,542 | 9.78% | 750,792 | Mar 31, 2024 |
| RBF CAPITAL, LLC | 0.26% | 0.01% | 142,807 | - | - | 192,789 | Mar 31, 2024 |
| XTX TOPCO LTD | 0.08% | 0.01% | 42,963 | 14,534 | 51.12% | 58,000 | Mar 31, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.75% | 0.00% | 961,271 | 356,593 | 58.97% | 1,296,000 | Mar 31, 2024 |
| FIDUCIARY TRUST CO | 0.39% | 0.00% | 215,000 | 100,000 | 86.96% | 290,250 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 2.19% | 0.00% | 1,205,524 | -17,827 | -1.46% | 1,627,000 | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | 0.38% | 0.00% | 209,600 | -900 | -0.43% | 282,960 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.37% | 0.00% | 201,153 | - | - | 271,557 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.58% | 0.00% | 865,739 | 77,564 | 9.84% | 1,168,748 | Mar 31, 2024 |
The largest Passage Bio shareholder by % of total assets is VERSANT VENTURE MANAGEMENT, LLC. The company owns 4.96M shares of Passage Bio (PASG), representing 6.49% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VESTAL POINT CAPITAL, LP | 8.19% | 0.50% | 4,500,000 | 4,500,000 | 100.00% | 6,075,000 | Mar 31, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | 8.82% | 1.70% | 4,845,871 | 4,466,712 | 1178.06% | 6,541,926 | Mar 31, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 1.75% | 0.00% | 961,271 | 356,593 | 58.97% | 1,296,000 | Mar 31, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.48% | 0.04% | 264,266 | 264,266 | 100.00% | 356,759 | Mar 31, 2024 |
| FIDUCIARY TRUST CO | 0.39% | 0.00% | 215,000 | 100,000 | 86.96% | 290,250 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.58% | 0.00% | 865,739 | 77,564 | 9.84% | 1,168,748 | Mar 31, 2024 |
| VANGUARD GROUP INC | 3.77% | 0.00% | 2,071,538 | 52,656 | 2.61% | 2,796,576 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.70% | - | 384,278 | 52,075 | 15.68% | 518,913 | Mar 31, 2024 |
| ACUITAS INVESTMENTS, LLC | 0.85% | 0.32% | 469,306 | 51,572 | 12.35% | 633,563 | Mar 31, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1.01% | 0.02% | 556,142 | 49,542 | 9.78% | 750,792 | Mar 31, 2024 |
| MARSHALL WACE, LLP | 0.04% | - | 21,990 | 21,990 | 100.00% | 29,687 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.04% | - | 20,300 | 18,700 | 1168.75% | 27,405 | Mar 31, 2024 |
| XTX TOPCO LTD | 0.08% | 0.01% | 42,963 | 14,534 | 51.12% | 58,000 | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.02% | 0.00% | 11,290 | 11,290 | 100.00% | 15,242 | Mar 31, 2024 |
| NORTHERN TRUST CORP | 0.15% | - | 84,267 | 7,382 | 9.60% | 113,760 | Mar 31, 2024 |
| FEDERATED HERMES, INC. | 0.00% | - | 783 | 783 | 100.00% | 1,057 | Mar 31, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 500 | 500 | 100.00% | 1,000 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.00% | - | 500 | 400 | 400.00% | 675 | Mar 31, 2024 |
| 0.00% | - | 225 | 225 | 100.00% | 333 | Mar 31, 2024 | |
| GOLDMAN SACHS GROUP INC | 0.05% | - | 26,954 | 58 | 0.22% | 36,388 | Mar 31, 2024 |
As of Mar 31 2024, Passage Bio's largest institutional buyer is VESTAL POINT CAPITAL, LP. The company purchased 4.50M stocks of PASG, valued at $6.08M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2.73% | 0.21% | 1,500,000 | -900,000 | -37.50% | 2,025,000 | Mar 31, 2024 |
| PALE FIRE CAPITAL SE | 0.26% | 0.03% | 141,435 | -439,822 | -75.67% | 190,937 | Mar 31, 2024 |
| BLACKROCK INC. | 1.68% | - | 922,547 | -100,016 | -9.78% | 1,245,438 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.40% | 0.00% | 221,552 | -90,161 | -28.92% | 299,095 | Mar 31, 2024 |
| FMR LLC | 0.04% | - | 21,070 | -40,951 | -66.03% | 28,445 | Mar 31, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -40,327 | -100.00% | - | Mar 31, 2024 |
| SCIENTECH RESEARCH LLC | - | - | - | -18,853 | -100.00% | - | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 2.19% | 0.00% | 1,205,524 | -17,827 | -1.46% | 1,627,000 | Mar 31, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -13,647 | -100.00% | - | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -2,089 | -100.00% | - | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 273 | -1,104 | -80.17% | 369 | Mar 31, 2024 |
| UBS GROUP AG | - | - | - | -1,059 | -100.00% | - | Mar 31, 2024 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | - | - | - | -1,010 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | 0.38% | 0.00% | 209,600 | -900 | -0.43% | 282,960 | Mar 31, 2024 |
| CITIGROUP INC | 0.01% | - | 3,969 | -829 | -17.28% | 5,358 | Mar 31, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.04% | - | 21,763 | -501 | -2.25% | 29,000 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | 1 | -31 | -96.88% | 1,000 | Mar 31, 2024 |
| VERSANT VENTURE MANAGEMENT, LLC | 9.03% | 6.49% | 4,959,769 | - | - | 6,695,688 | Mar 31, 2024 |
| NEW LEAF VENTURE PARTNERS, L.L.C. | 4.55% | 2.95% | 2,497,922 | - | - | 3,372,195 | Mar 31, 2024 |
| ORBIMED ADVISORS LLC | 18.43% | 0.25% | 10,124,576 | - | - | 13,668,178 | Mar 31, 2024 |
As of Mar 31 2024, Passage Bio's biggest institutional seller is TANG CAPITAL MANAGEMENT LLC. The company sold -0.90M shares of PASG, valued at $2.02M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VESTAL POINT CAPITAL, LP | 8.19% | 0.50% | 4,500,000 | 4,500,000 | 100.00% | 6,075,000 | Mar 31, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 0.48% | 0.04% | 264,266 | 264,266 | 100.00% | 356,759 | Mar 31, 2024 |
| MARSHALL WACE, LLP | 0.04% | - | 21,990 | 21,990 | 100.00% | 29,687 | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.02% | 0.00% | 11,290 | 11,290 | 100.00% | 15,242 | Mar 31, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 500 | 500 | 100.00% | 1,000 | Mar 31, 2024 |
| 0.00% | - | 225 | 225 | 100.00% | 333 | Mar 31, 2024 | |
| - | - | 10 | 10 | 100.00% | 14 | Mar 31, 2024 |
Passage Bio's largest new institutional shareholder by number of shares is VESTAL POINT CAPITAL, LP, purchased 4.50M shares, valued at $6.08M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TWO SIGMA SECURITIES, LLC | - | - | - | -40,327 | -100.00% | - | Mar 31, 2024 |
| SCIENTECH RESEARCH LLC | - | - | - | -18,853 | -100.00% | - | Mar 31, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -13,647 | -100.00% | - | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -2,089 | -100.00% | - | Mar 31, 2024 |
| UBS GROUP AG | - | - | - | -1,059 | -100.00% | - | Mar 31, 2024 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | - | - | - | -1,010 | -100.00% | - | Mar 31, 2024 |
Passage Bio's largest sold out institutional shareholder by shares sold is TWO SIGMA SECURITIES, LLC, sold -40.33K shares, valued at -, as of undefined.
Passage Bio Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| CORNERCAP GROUP OF FUNDS /VA/ | 0.71% | 51,410 | 18,951 | 58.38% | Sep 30, 2022 |
| BRIDGEWAY FUNDS INC | 0.20% | 506,600 | - | - | Dec 29, 2023 |
| IndexIQ ETF Trust | 0.08% | 184,153 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.08% | 38,001 | - | - | Dec 31, 2023 |
| BlackRock Health Sciences Trust II | 0.07% | 185,056 | - | - | Dec 31, 2023 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.06% | 10,758 | - | - | Dec 29, 2023 |
| FIDELITY ADVISOR SERIES VII | 0.04% | 316,659 | - | - | Jan 31, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.03% | 99,285 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.02% | 8,140 | - | - | Dec 31, 2023 |
| ACAP Strategic Fund | 0.02% | 238,499 | - | - | Dec 31, 2023 |
| ETFis Series Trust I | 0.02% | 23,317 | - | - | Jan 31, 2024 |
| ROYCE FUND | 0.01% | 84,000 | - | - | Dec 31, 2023 |
| FIDELITY CONTRAFUND | 0.01% | 893,722 | - | - | Dec 31, 2023 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,678 | - | - | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 59,966 | - | - | Dec 31, 2023 |
| MORGAN STANLEY INSTITUTIONAL FUND INC | 0.01% | 436,356 | - | - | Dec 31, 2023 |
| Humankind Benefit Corp | 0.01% | 147 | - | - | Dec 31, 2023 |
| Fidelity Commonwealth Trust II | 0.01% | 38,538 | - | - | Aug 31, 2023 |
| FEDERATED HERMES INSURANCE SERIES | 0.01% | 24,000 | - | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.01% | 2,377,729 | 441,573 | 22.81% | Dec 31, 2023 |
| FIDELITY MT VERNON STREET TRUST | 0.01% | 147,082 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.00% | 43,581 | - | - | Dec 31, 2023 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 1,084 | - | - | Dec 31, 2023 |
| Nushares ETF Trust | 0.00% | 31,897 | - | - | Jan 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 57,028 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.00% | 7,304 | - | - | Dec 31, 2023 |
| FIDELITY SECURITIES FUND | 0.00% | 192,822 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 21,054 | - | - | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 304,240 | 3,927 | 1.31% | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 42,620 | - | - | Dec 31, 2023 |
| Calvert Variable Products, Inc. | 0.00% | 2,908 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 156,900 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 30,974 | - | - | Dec 31, 2023 |
| Trust for Advised Portfolios | 0.00% | 18,274 | - | - | Dec 31, 2023 |
| SCHWAB STRATEGIC TRUST | 0.00% | 161,429 | - | - | Feb 29, 2024 |
| FINANCIAL INVESTORS TRUST | 0.00% | 67,429 | - | - | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 97,619 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 32,574 | - | - | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 6,127 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 14,517 | - | - | Dec 31, 2023 |
| OHIO NATIONAL FUND INC | 0.00% | 8,622 | - | - | Dec 31, 2023 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,700 | - | - | Dec 31, 2023 |
| VANGUARD WORLD FUND | 0.00% | 80,832 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 656 | - | - | Dec 31, 2023 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 12,516 | - | - | Dec 31, 2023 |
| SunAmerica Specialty Series | 0.00% | 112 | - | - | Apr 30, 2021 |
| HC CAPITAL TRUST | 0.00% | 5,600 | - | - | Dec 31, 2023 |
| GOLDMAN SACHS TRUST | 0.00% | 22,558 | - | - | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 268,663 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 128,826 | - | - | Dec 31, 2023 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 8,451 | - | - | Dec 31, 2023 |
| Fidelity Rutland Square Trust II | 0.00% | 113,000 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 793 | - | - | Jan 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 353 | - | - | Dec 31, 2023 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 7,000 | - | - | Dec 31, 2023 |
| FIDELITY CAPITAL TRUST | 0.00% | 830 | - | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,249 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 126,830 | - | - | Feb 29, 2024 |
| RBB FUND, INC. | 0.00% | 5,820 | - | - | Feb 29, 2024 |
| FundVantage Trust | 0.00% | 274 | - | - | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,600 | - | - | Dec 29, 2023 |
| FIDELITY ADVISOR SERIES I | 0.00% | 9,869 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 196 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 13,747 | - | - | Feb 29, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 4,360 | - | - | Dec 29, 2023 |
| Guggenheim Active Allocation Fund | 0.00% | 220 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 4,947 | - | - | Dec 31, 2023 |
| SPDR SERIES TRUST | 0.00% | 1,245,751 | - | - | Dec 31, 2023 |
| RYDEX VARIABLE TRUST | 0.00% | 36 | - | - | Dec 31, 2023 |
| Blackstone Alternative Investment Funds | 0.00% | 3,200 | - | - | Dec 31, 2023 |
| ADVANCED SERIES TRUST | 0.00% | 99,949 | - | - | Dec 29, 2023 |
| PGIM ETF TRUST | 0.00% | 1,530 | - | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 143,703 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 18,674 | - | - | Dec 29, 2023 |
| VANGUARD WELLINGTON FUND | 0.00% | 7,430 | - | - | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 4,581 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 47,580 | - | - | Dec 31, 2023 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 1,729 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,516 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 31,700 | - | - | Dec 31, 2023 |
| SUNAMERICA SERIES TRUST | 0.00% | 4,090 | - | - | Jan 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 772 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 7,658 | - | - | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 96,043 | - | - | Feb 29, 2024 |
| PACIFIC SELECT FUND | 0.00% | 18,752 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 10,730 | - | - | Dec 31, 2023 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 1,460 | - | - | Dec 31, 2023 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 3,244 | - | - | Dec 31, 2023 |
| Advisors' Inner Circle Fund III | 0.00% | 39 | - | - | Jan 31, 2024 |
| Bridge Builder Trust | 0.00% | 13,897 | - | - | Dec 31, 2023 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 5,948 | - | - | Dec 31, 2023 |
| WisdomTree Trust | 0.00% | 2,709 | - | - | Feb 29, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 188 | - | - | Dec 31, 2023 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 1,256 | - | - | Dec 31, 2023 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 8,300 | - | - | Feb 29, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 2,159 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 4,246 | - | - | Feb 29, 2024 |
Passage Bio's largest mutual fund holder by % of total assets is "CORNERCAP GROUP OF FUNDS /VA/", owning 51.41K shares, compromising 0.71% of its total assets.
Passage Bio Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 49 | 2.08% |
| 31 Dec, 23 | 48 | - |
| 30 Sep, 23 | 48 | -9.43% |
| 30 Jun, 23 | 53 | -3.64% |
| 31 Mar, 23 | 55 | -14.06% |
| 31 Dec, 22 | 64 | -4.48% |
| 30 Sep, 22 | 67 | -12.99% |
| 30 Jun, 22 | 77 | -23.76% |
| 31 Mar, 22 | 101 | 4.12% |
| 31 Dec, 21 | 97 | -3.96% |
| 30 Sep, 21 | 101 | - |
| 30 Jun, 21 | 101 | 13.48% |
| 31 Mar, 21 | 89 | 25.35% |
| 31 Dec, 20 | 71 | 5.97% |
| 30 Sep, 20 | 67 | 1.52% |
| 30 Jun, 20 | 66 | 46.67% |
| 31 Mar, 20 | 45 | - |
As of 31 Mar 24, 49 institutions are holding Passage Bio's shares, representing an increase of 2.08% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 37,821,836 | 27.03% |
| 31 Dec, 23 | 29,773,776 | -0.82% |
| 30 Sep, 23 | 30,020,671 | -3.78% |
| 30 Jun, 23 | 31,198,832 | -8.17% |
| 31 Mar, 23 | 33,975,602 | -5.12% |
| 31 Dec, 22 | 35,808,274 | -6.36% |
| 30 Sep, 22 | 38,240,282 | -6.71% |
| 30 Jun, 22 | 40,991,561 | -2.29% |
| 31 Mar, 22 | 41,954,183 | -2.89% |
| 31 Dec, 21 | 43,203,667 | 2.67% |
| 30 Sep, 21 | 42,081,069 | -5.57% |
| 30 Jun, 21 | 44,561,344 | -0.92% |
| 31 Mar, 21 | 44,975,951 | 40.64% |
| 31 Dec, 20 | 31,980,467 | 3.92% |
| 30 Sep, 20 | 30,774,592 | -2.61% |
| 30 Jun, 20 | 31,599,027 | 8.39% |
| 31 Mar, 20 | 29,151,968 | - |
Passage Bio (PASG) has 37.82M shares outstanding as of 31 Mar 24, up 27.03% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 68.84% | 2.33% |
| 31 Dec, 23 | 54.34% | 1.80% |
| 30 Sep, 23 | 54.90% | 1.68% |
| 30 Jun, 23 | 57.12% | 1.48% |
| 31 Mar, 23 | 62.20% | 1.44% |
| 31 Dec, 22 | 65.79% | 1.34% |
| 30 Sep, 22 | 70.20% | 1.24% |
| 30 Jun, 22 | 75.37% | 1.26% |
| 31 Mar, 22 | 77.30% | 1.18% |
| 31 Dec, 21 | 80.99% | 1.33% |
| 30 Sep, 21 | 77.93% | 1.14% |
| 30 Jun, 21 | 82.70% | 1.08% |
| 31 Mar, 21 | 87.62% | 1.78% |
| 31 Dec, 20 | 70.11% | 1.53% |
| 30 Sep, 20 | 67.63% | 1.40% |
| 30 Jun, 20 | 69.62% | 1.69% |
| 31 Mar, 20 | 64.23% | - |
As of 31 Mar 24, Passage Bio is held by 68.84% institutional shareholders, representing a 2.33% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 21 | 5.00% |
| 31 Dec, 23 | 20 | 42.86% |
| 30 Sep, 23 | 14 | -12.50% |
| 30 Jun, 23 | 16 | -15.79% |
| 31 Mar, 23 | 19 | -17.39% |
| 31 Dec, 22 | 23 | -4.17% |
| 30 Sep, 22 | 24 | -25.00% |
| 30 Jun, 22 | 32 | -39.62% |
| 31 Mar, 22 | 53 | -7.02% |
| 31 Dec, 21 | 57 | 21.28% |
| 30 Sep, 21 | 47 | -24.19% |
| 30 Jun, 21 | 62 | 1.64% |
| 31 Mar, 21 | 61 | 29.79% |
| 31 Dec, 20 | 47 | 62.07% |
| 30 Sep, 20 | 29 | -30.95% |
| 30 Jun, 20 | 42 | -6.67% |
| 31 Mar, 20 | 45 | - |
21 institutional shareholders have increased their position in PASG stock as of 31 Mar 24 compared to 20 in the previous quarter (a 5.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 11 | 22.22% |
| 31 Dec, 23 | 9 | -30.77% |
| 30 Sep, 23 | 13 | -27.78% |
| 30 Jun, 23 | 18 | 20.00% |
| 31 Mar, 23 | 15 | -37.50% |
| 31 Dec, 22 | 24 | -17.24% |
| 30 Sep, 22 | 29 | -14.71% |
| 30 Jun, 22 | 34 | 9.68% |
| 31 Mar, 22 | 31 | 40.91% |
| 31 Dec, 21 | 22 | -29.03% |
| 30 Sep, 21 | 31 | 82.35% |
| 30 Jun, 21 | 17 | 30.77% |
| 31 Mar, 21 | 13 | 18.18% |
| 31 Dec, 20 | 11 | -45.00% |
| 30 Sep, 20 | 20 | 53.85% |
| 30 Jun, 20 | 13 | - |
| 31 Mar, 20 | - | - |
11 institutional shareholders have reduced their position in PASG stock as of 31 Mar 24 compared to 9 in the previous quarter (a 22.22% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 49 | 2.08% | 37,821,836 | 27.03% | 68.84% | 2.33% | 21 | 5.00% | 11 | 22.22% |
| 31 Dec, 23 | 48 | - | 29,773,776 | -0.82% | 54.34% | 1.80% | 20 | 42.86% | 9 | -30.77% |
| 30 Sep, 23 | 48 | -9.43% | 30,020,671 | -3.78% | 54.90% | 1.68% | 14 | -12.50% | 13 | -27.78% |
| 30 Jun, 23 | 53 | -3.64% | 31,198,832 | -8.17% | 57.12% | 1.48% | 16 | -15.79% | 18 | 20.00% |
| 31 Mar, 23 | 55 | -14.06% | 33,975,602 | -5.12% | 62.20% | 1.44% | 19 | -17.39% | 15 | -37.50% |
| 31 Dec, 22 | 64 | -4.48% | 35,808,274 | -6.36% | 65.79% | 1.34% | 23 | -4.17% | 24 | -17.24% |
| 30 Sep, 22 | 67 | -12.99% | 38,240,282 | -6.71% | 70.20% | 1.24% | 24 | -25.00% | 29 | -14.71% |
| 30 Jun, 22 | 77 | -23.76% | 40,991,561 | -2.29% | 75.37% | 1.26% | 32 | -39.62% | 34 | 9.68% |
| 31 Mar, 22 | 101 | 4.12% | 41,954,183 | -2.89% | 77.30% | 1.18% | 53 | -7.02% | 31 | 40.91% |
| 31 Dec, 21 | 97 | -3.96% | 43,203,667 | 2.67% | 80.99% | 1.33% | 57 | 21.28% | 22 | -29.03% |
| 30 Sep, 21 | 101 | - | 42,081,069 | -5.57% | 77.93% | 1.14% | 47 | -24.19% | 31 | 82.35% |
| 30 Jun, 21 | 101 | 13.48% | 44,561,344 | -0.92% | 82.70% | 1.08% | 62 | 1.64% | 17 | 30.77% |
| 31 Mar, 21 | 89 | 25.35% | 44,975,951 | 40.64% | 87.62% | 1.78% | 61 | 29.79% | 13 | 18.18% |
| 31 Dec, 20 | 71 | 5.97% | 31,980,467 | 3.92% | 70.11% | 1.53% | 47 | 62.07% | 11 | -45.00% |
| 30 Sep, 20 | 67 | 1.52% | 30,774,592 | -2.61% | 67.63% | 1.40% | 29 | -30.95% | 20 | 53.85% |
| 30 Jun, 20 | 66 | 46.67% | 31,599,027 | 8.39% | 69.62% | 1.69% | 42 | -6.67% | 13 | - |
| 31 Mar, 20 | 45 | - | 29,151,968 | - | 64.23% | - | 45 | - | - | - |
Passage Bio Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Passage Bio's stock was made by Borthwick Kathleen on Feb 13 2024, selling 1,470 shares at $0.97 per share (valued at $1.43K).
Passage Bio Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 2 | 7 | 28.57% |
| Q4 2023 | 3 | 3 | 100.00% |
| Q3 2023 | 3 | 6 | 50.00% |
| Q2 2023 | 11 | 4 | 275.00% |
| Q1 2023 | 5 | - | - |
| Q4 2022 | 6 | 3 | 200.00% |
| Q3 2022 | 2 | 2 | 100.00% |
| Q2 2022 | 29 | - | - |
| Q1 2022 | 17 | - | - |
| Q4 2021 | 1 | 2 | 50.00% |
| Q3 2021 | 4 | - | - |
| Q2 2021 | 11 | 2 | 550.00% |
| Q1 2021 | 12 | 4 | 300.00% |
| Q1 2020 | 49 | 37 | 132.43% |
2 total buy trades, and 7 total sell trades (buy/sell ratio of 0.29%) were made by Passage Bio's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | - | 5 | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | 1 | - |
| Q2 2023 | 2 | 2 | 100.00% |
| Q1 2023 | - | - | - |
| Q4 2022 | - | 2 | - |
| Q3 2022 | - | 1 | - |
| Q2 2022 | 3 | - | - |
| Q1 2022 | 9 | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | 2 | - | - |
| Q1 2021 | - | 4 | - |
| Q1 2020 | 19 | - | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 5 open market sell trades of Passage Bio's stocks.
PASG Ownership FAQ
Who Owns Passage Bio?
Passage Bio is owned by institutional shareholders (68.84%), insiders (0.49%), and public (30.68%). The largest institutional shareholder of Passage Bio is ORBIMED ADVISORS LLC (18.43% of total shares) and the top mutual fund owner is CORNERCAP GROUP OF FUNDS /VA/ (0.71% of total shares).
Who are the major institutional shareholders of Passage Bio?
Passage Bio's major institutional shareholders are ORBIMED ADVISORS LLC, VERSANT VENTURE MANAGEMENT, LLC, LYNX1 CAPITAL MANAGEMENT LP, VESTAL POINT CAPITAL, LP, and NEW LEAF VENTURE PARTNERS, L.L.C.. The top five shareholders own together 49.01% of the company's share outstanding.
How many Passage Bio shareholders are there?
As of Mar 2024, there are 49 institutional shareholders of Passage Bio.
What percentage of Passage Bio is owned by ORBIMED ADVISORS LLC?
ORBIMED ADVISORS LLC owns 10.12M shares of Passage Bio, representing 18.43% of the company's total shares outstanding, valued at $13.67M (as of Mar 2024).
What percentage of Passage Bio is owned by VERSANT VENTURE MANAGEMENT, LLC?
As of Mar 2024, VERSANT VENTURE MANAGEMENT, LLC holds 4.96M shares of Passage Bio (PASG), compromising 9.03% of the company, valued at $6.7M.
What percentage of Passage Bio is owned by LYNX1 CAPITAL MANAGEMENT LP?
LYNX1 CAPITAL MANAGEMENT LP is the third largest holder of Passage Bio. The company owns 4.85M of the company's shares outstanding (worth $6.54M).